Mikulski sees flat funding harming critical research

Flat funding for medical research at the National Institutes of Health could stall critical medical research and hurt research institutions like those in Baltimore, Sen. Barbara Mikulski said Tuesday.

“Cuts to NIH funding slow down our transition from science to treatment,” Mikulski said at a conference at the University of Maryland School of Medicine. “We must continue to invest in biomedical research. We cannot turn backwards.”